The Statesboro community is rallying behind U.S. Army veteran Matthew Kleinsorge, a devoted father of four, as he battles ...

A cancer survivor who has waited almost eight years to get a breast reconstruction will finally get her surgery next month. Gail Agar from Aberdeenshire had a mastectomy - an operation to remove her ...

Researchers and physicians at Sunnybrook Health Sciences Centre and The Hospital for Sick Children (SickKids) are the first ...

Medically reviewed by Karina Tolentino, RD Metastatic breast cancer (MBC) and the therapies used to treat it can adversely ...

Mom of 3 Molly Pardue was diagnosed with cervical cancer after demanding a pap smear — and underwent chemotherapy and other ...

Atezolizumab (Tecentriq) plus chemotherapy after surgery did not improve survival in high-risk triple-negative breast cancer, according to a global phase 3 trial.

The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

Henry Ford Health System in Detroit recently provided the first patient in Michigan — a 60-year-old man from the Cadillac ...

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...

Raising money to fight pediatric cancer was the focus of a Tuesday assembly at Grand Valley High School. Dan Kingsley, a childhood cancer survivor and cancer researcher at Case Western Reserve ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.